<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03886454</url>
  </required_header>
  <id_info>
    <org_study_id>IRB # 12489</org_study_id>
    <nct_id>NCT03886454</nct_id>
  </id_info>
  <brief_title>Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study</brief_title>
  <official_title>Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Natalie V. Zucker Research Grant</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tufts Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to characterize airflow patterns during bronchoscopy under conscious
      sedation, and determine the incidence of obstructive and central respiratory events. The
      investigators also plan to monitor the degree and frequency of oxygen desaturation throughout
      the procedure. To achieve this, investigators use a physiologic monitoring device (NOX T3,
      K082113) that has been FDA approved for the screening and diagnosis of sleep disordered
      breathing [1]. The results from this pilot study will be used to assess the feasibility of a
      prospective study utilizing continuous external negative pressure (Pneuway). This negative
      pressure is applied through a neck mask to alleviate upper airway collapsibility and can
      potentially decrease the number of apneas during bronchoscopy under conscious sedation [2].
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and Rationale:

      Diagnostic bronchoscopic procedures are commonly performed in patients with various forms of
      pulmonary disorders associated with abnormal chest imaging. During these procedures, the
      vocal cords are intubated using a flexible scope. Patients need sedation and analgesia, and
      conscious sedation is typically administered. Hypoxemia is a potential complication during
      bronchoscopy. Contributing factors in addition to the underlying lung pathology, include
      depression of the respiratory center and decreased upper airway muscle tone that occur during
      conscious sedation [3]. Upper airway obstruction including obstructive apnea is often
      unrecognized during these procedures till hypoxemia is apparent [4]. Propofol, a common drug
      used for conscious sedation, is known to cause respiratory depression, and potentially
      central and/or obstructive apneas with a direct dose-response pattern [5]. Others, including
      benzodiazepines and opiates, can also cause respiratory depression leading to central or
      obstructive events. Respiratory depression is potentiated when any of the above medications
      are combined [6].

      Objectives:

      The objective of the study is to identify the incidence of airflow limitation during
      bronchoscopy under conscious sedation, and further characterize it as obstructive or central.
      The primary endpoint is the incidence of obstructive and central apneic events during
      bronchoscopic procedures. The secondary outcomes include incidence of oxygen desaturation and
      need for escalation of care.

      Study Design:

      After informed consent is obtained, the NOX-T3 monitoring system, a commonly used portable
      sleep device that detects obstructive and central apneas, is placed prior to starting the
      procedure, and remains in place up to 30 minutes following the procedure. The NOX-T3
      monitoring system includes a nasal cannula that sits over the nares, an elastic band that
      goes around the chest, and another one that goes around the abdomen, and a finger probe that
      is placed on the index finger. All subjects undergo bronchoscopy with standard of care
      including the monitoring of blood pressure, respiratory rate and oxygen saturation. All
      subjects have the NOX-T3 applied in addition to standard of care monitoring. Data is assessed
      following the completion of the procedure. Subjects' participation in this study ends at the
      completion of their standard of care visit. All the NOX-T3 studies are scored and interpreted
      by study investigators.

      Data Management:

      This is an observational and descriptive study with an estimated sample size of 30. Data
      collected will be reviewed with a statistician and investigators will report on patients'
      demographics. The study investigators will also present the incidence of apneic respiratory
      events and characterize them as obstructive or centrals. Investigators will further
      differentiate obstructive respiratory events to either apneas or hypopnea. Data on oxygen
      desaturations unrelated to apneic events will also be recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 19, 2017</start_date>
  <completion_date type="Actual">July 1, 2019</completion_date>
  <primary_completion_date type="Actual">June 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of obstructive and central apneic events.</measure>
    <time_frame>Throughout the bronchoscopic procedure.</time_frame>
    <description>Obstructive apnea are defined as more than 90% cessation of air-flow that lasts for at least 10 seconds, despite the presence of respiratory and abdominal muscle effort. Obstructive hypopnea is when more than 30% cessation of air-flow occurs that lasts for at least 10 seconds, and is associated with oxygen desaturation of at least 3% from baseline. Central apnea is when cessation of air-flow occurs secondary to absent respiratory and abdominal muscle effort, that lasts for at least 10 seconds.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxygen desaturation</measure>
    <time_frame>Throughout the bronchoscopic procedure.</time_frame>
    <description>Oxygen desaturation of more than 3% from baseline which are unrelated to apneic events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for escalation of care</measure>
    <time_frame>Throughout the bronchoscopic procedure.</time_frame>
    <description>Need for escalation of care, including but not limited to, increasing supplemental oxygen, jaw thrust, patient stimulation or interrupting the administration of conscious sedation drug.</description>
  </secondary_outcome>
  <enrollment type="Actual">33</enrollment>
  <condition>Conscious Sedation</condition>
  <condition>Bronchoscopy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who have been referred to the pulmonary division at Tufts Medical Center for
        bronchoscopy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with respiratory pathology that require bronchoscopy for further diagnostic
             evaluation, as part of standard of care

          2. Age of 18 years or older.

          3. Our study does not include the recruitment of vulnerable populations such as
             cognitively impaired adults, pregnant women, pregnant minors, minors, wards of the
             state, non-viable neonates, neonates of uncertain viability and prisoners.

        Exclusion Criteria:

          1. Oxygen requirement of more than 4 Liter prior to procedure.

          2. Intubation or any airway support.

          3. Presence of severe cardiopulmonary or neurologic disease as determined by the
             investigator.

          4. Nasal congestion/obstruction preventing proper placement and monitoring of air flow

          5. Inability to provide informed consent.

          6. All vulnerable population mentioned above.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khalid Ismail, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tufts Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cairns A, Wickwire E, Schaefer E, Nyanjom D. A pilot validation study for the NOX T3(TM) portable monitor for the detection of OSA. Sleep Breath. 2014 Sep;18(3):609-14. doi: 10.1007/s11325-013-0924-2. Epub 2014 Jan 19.</citation>
    <PMID>24442914</PMID>
  </reference>
  <reference>
    <citation>Kais SS, Klein KB, Rose RM, Endemann S, Coyle WJ. Continuous negative external pressure (cNEP) reduces respiratory impairment during screening colonoscopy: a pilot study. Endoscopy. 2016 Jun;48(6):584-7. doi: 10.1055/s-0042-102533. Epub 2016 Apr 25.</citation>
    <PMID>27110692</PMID>
  </reference>
  <reference>
    <citation>Hillman DR, Platt PR, Eastwood PR. The upper airway during anaesthesia. Br J Anaesth. 2003 Jul;91(1):31-9. Review.</citation>
    <PMID>12821563</PMID>
  </reference>
  <reference>
    <citation>Vargo JJ, Zuccaro G Jr, Dumot JA, Conwell DL, Morrow JB, Shay SS. Automated graphic assessment of respiratory activity is superior to pulse oximetry and visual assessment for the detection of early respiratory depression during therapeutic upper endoscopy. Gastrointest Endosc. 2002 Jun;55(7):826-31.</citation>
    <PMID>12024135</PMID>
  </reference>
  <reference>
    <citation>Eastwood PR, Platt PR, Shepherd K, Maddison K, Hillman DR. Collapsibility of the upper airway at different concentrations of propofol anesthesia. Anesthesiology. 2005 Sep;103(3):470-7.</citation>
    <PMID>16129969</PMID>
  </reference>
  <reference>
    <citation>Jos√© RJ, Shaefi S, Navani N. Sedation for flexible bronchoscopy: current and emerging evidence. Eur Respir Rev. 2013 Jun 1;22(128):106-16. doi: 10.1183/09059180.00006412. Review.</citation>
    <PMID>23728864</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>March 20, 2019</study_first_submitted>
  <study_first_submitted_qc>March 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2019</study_first_posted>
  <last_update_submitted>August 27, 2019</last_update_submitted>
  <last_update_submitted_qc>August 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Central apnea</keyword>
  <keyword>Obstructive apnea</keyword>
  <keyword>Oxygen desaturation</keyword>
  <keyword>Escalation of Care</keyword>
  <keyword>conscious sedation</keyword>
  <keyword>Bronchoscopy</keyword>
  <keyword>Respiratory impairment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Plan is to make IPD available to sommetrics Inc. to review once the study is complete. Data would include all the information obtained on the NOX-T3 device during conscious sedation which includes, but is not limited to, heart rate, respiratory rate, air flow through nasal cannula, oxygen saturation and chest and abdominal wall movements.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>IPD will become available after completion of the study and will be available to review for 1 year thereafter.</ipd_time_frame>
    <ipd_access_criteria>IPD that is acquired by the NOX-T3 device is transferred to NOX-T3 software. Plan is to share IPD with sommetrics Inc. via that software.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

